Bob Leasure is the CEO, president, and a director of Inotiv (Bioanalytical Systems, Inc. or BASi), roles that he has held since January 2019. He brings more than 30 years of experience in turnarounds, restructurings, financings, mergers and acquisitions, and in building and mentoring management teams.
Prior to being promoted to CEO, Leasure joined the BASi management team in September 2016 as a consultant with management consulting firm LS Associates. In this role, he worked closely with the BASi team and board of directors to guide operations and assist the company in restructuring, developing a growth strategy, initiating major expansion, and completing acquisitions. Leasure continues to serve as the managing partner and president of LS Associates LLC, formed in 2002. Over the last 16 years, LS has worked with over 300 companies in various industries and served clients in the United States and internationally.